10.22.21 Advocacy Alert: Hochul Signs Parolee Employment Legislation
Blog Categories
October 22, 2021
Today, Governor Kathy Hochul signed S.2803/A.5707 into law. This legislation reduces barriers to employment for formerly incarcerated individuals.
Curfews are commonly included in probation or conditional discharge sentences. These restrictions can prevent the formerly incarcerated from working second- and third-shift jobs, limiting their job prospects.
This is one of many barriers to employment for parolees. 27.3% of formerly incarcerated individuals are unemployed, and employment is associated with reduced recidivism.
This legislation addresses the curfew problem by providing that “performance of bona fide work for an employer, including travel time” shall not be considered a violation of a probation or conditional discharge sentence. Effectively, this means parolees can work during their curfew times.
The BNP supported this legislation. This legislation can help employers address workforce shortages and reduces barriers to successful reentry.
Related Posts
2.10.22 COVID Bulletin: BNP Gets Answers on Masking and HERO Act
Yesterday, Governor Kathy Hochul announced she would repeal the state’s mask mandate, effective today. However, her announcement did not proactively address how the repeal coincided with the NY HERO Act, which would have required employees in most workplaces to continue masking.
2.9.22 COVID-19 Bulletin: Hochul Ends Mask Mandate; Poloncarz Will Follow Suit
Today, Governor Kathy Hochul announced she will NOT be renewing the state’s mask mandate, so the mandate will expire tomorrow.
1.28.22 COVID-19 Bulletin: Hochul Extends Mask Mandate
Today, Gov. Kathy Hochul extended the state’s mask mandate for indoor public places through February 10th. The mandate was previously set to expire on Tuesday.
1.13.22 COVID-19 Bulletin: SCOTUS Blocks Vax-or-Test Rule
This afternoon, the U.S. Supreme Court blocked OSHA’s emergency rule that required employees at workplaces of 100 or more to be vaccinated against COVID-19 or test weekly.